C. Gu

发表

Positron Emission Tomography in Staging Early Lung Cancer

Y. Ung, G. Darling, M. Levine, 2009, Annals of Internal Medicine.

External validation of the SOX‐PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis

S. Goldhaber, S. Kahn, S. Vedantham, 2020, Journal of thrombosis and haemostasis : JTH.

A prospective study to evaluate the role of 2-[18f] fluoro-2-deoxy-d-glucose (FDG)-positron emission tomography (PET), breast magnetic resonance imaging (MRI), and breast ultrasonography in monitoring tumor responses in patients with locally advanced breast cancer (LABC) undergoing neoadjuvant chemo

K. Gulenchyn, J. Julian, N. Hodgson, 2010 .

F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer

K. Pritchard, M. Levine, K. Gulenchyn, 2015 .

Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial

Y. Ung, G. Darling, M. Levine, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis

S. Goldhaber, M. Jaff, D. Cohen, 2017, The New England journal of medicine.

Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial.

A. Gafni, C. Moulton, S. Gallinger, 2016, Journal of oncology practice.

Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial.

M. Haider, C. Moulton, S. Gallinger, 2014, JAMA.

Positron Emission Tomography in Staging Early Lung CancerA Randomized Trial

Y. Ung, G. Darling, M. Levine, 2009 .

Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases

C. Moulton, S. Gallinger, M. Levine, 2019, Journal of surgical oncology.

Does giving pasireotide to patients undergoing pancreaticoduodenectomy always pay for itself?

A. Gafni, C. Gu, P. Serrano, 2018, European Surgery.

Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial

S. Kahn, S. Schulman, D. T. Nguyen, 2020, Seminars in Thrombosis and Hemostasis.

Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial

S. Goldhaber, S. Kahn, T. Murphy, 2019, Thrombosis and Haemostasis.

Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial

C. Earle, T. Vandenberg, M. Trudeau, 2021, BMJ.

New and known predictors of the postthrombotic syndrome: A subanalysis of the ATTRACT trial

S. Kahn, S. Vedantham, C. Gu, 2022, Research and practice in thrombosis and haemostasis.

An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).

M. Haider, C. Moulton, S. Gallinger, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis

S. Goldhaber, S. Kahn, J. Julian, 2020 .

Abstract GS4-03: RAPID: A randomized trial of accelerated partial breast irradiation using 3-dimensional conformal radiotherapy (3D-CRT)

T. Whelan, A. Nichol, W. Beckham, 2019, General Session Abstracts.

Effect of PET‐CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long‐term results of a randomized controlled trial

C. Moulton, S. Gallinger, M. Levine, 2020, Journal of surgical oncology.

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.

C. Catton, P. Warde, G. Bauman, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial

Do-Hoon Kim, R. Vandermeer, T. Whelan, 2019, The Lancet.

Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial

L. Hofmann, S. Goldhaber, M. Jaff, 2019, Circulation.

Exploring the Villalta scale to capture postthrombotic syndrome using alternative approaches: A subanalysis of the ATTRACT trial

S. Kahn, S. Vedantham, C. Gu, 2022, Research and practice in thrombosis and haemostasis.

Simultaneous versus staged resection for synchronous colorectal liver metastases: a population-based cost analysis in Ontario, Canada - Health Economic Evaluation.

A. Gafni, L. Ruo, J. Hallet, 2020, International journal of surgery.

Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC).

R. Gilbert, J. Waldron, L. Eapen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.

J. Kaufman, S. Goldhaber, M. Jaff, 2020, Journal of vascular surgery. Venous and lymphatic disorders.

Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer

Gregory R. Pond, David D’Souza, Timothy J. Whelan, 2018, JAMA network open.

An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.

Y. Ung, E. Yu, G. Darling, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer

S. Solymoss, J. Julian, H. Liebman, 2012, Journal of thrombosis and haemostasis : JTH.